GE Healthcare Technologies Inc. GEHC

GE HealthCare raised its quarterly dividend to $0.04 per share on Sept. 22 after Q2 revenue rose to $5.3 billion and adjusted earnings climbed to $1.13.

GE HealthCare and AsiaMedic today announced that AsiaMedic is the first site in ASEAN, and among the earliest adopters in Asia Pacific, to implement MR31 — the latest generation of GE HealthCare's MRI platform. The adoption expands the range of complex imaging examinations available at AsiaMedic's imaging centre in Singapore.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at GE HealthCare (NASDAQ:GEHC) and the best and worst performers in the healthcare equipment and supplies industry.

Growth is driven by rising cardiovascular disease, telehealth adoption, and advances in wearable ECG devices, implantable monitors, AI analytics, and cloud platforms. North America leads, while Asia-Pacific is expected to grow fastest.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Remote Cardiac Monitoring Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.The global Remote Cardiac Monitoring Mark

Needham thinks the worst-case outcome for the MRI, CT, and ultrasound machine maker may already be fading.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) specializes in hospital imaging, including MRI, CT, and ultrasound machines, and the contrast agents required to interpret scans. Spun out of General Electric in early 2023, GE HealthCare traded near its 52-week low of $58.75 and 28% below its high of $89.77, at a closing price of $64.81 on September […]

CHICAGO, September 22, 2026--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The dividend will be payable on November 13, 2026, to all shareholders of record as of October 23, 2026.

CHICAGO, September 22, 2026--GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr. Desroches brings more than 30 years of leadership experience across finance, governance, and large-scale technology and digital transformation.

Needham initiated coverage with a ‘Buy’ rating and $93 price target, putting GEHC among the stocks it expects to outperform.

GE HealthCare Technologies (GEHC) just launched CareIntellect for Operations, an AI SaaS tool that forecasts hospital capacity constraints up to 72 hours ahead and suggests actions, giving investors another data point on its software push. Despite the AI push, GE HealthCare Technologies shares have been under pressure, with the 30-day share price return down 13.38% and the year-to-date share price return down 21.75%, while the 1-year total shareholder return has declined 13.16% and the 3-year...

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is reportedly discussing a possible $1 billion acquisition of Sofie Biosciences. Reuters reported the talks on September 13, citing the Financial Times, which attributed them to people familiar with the matter. Reuters could not independently verify the report, and no agreement was confirmed in its coverage. The strategic question starts […]